Press releases
- ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment
- GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient (dMMR) solid cancers at ASCO Gastrointestinal Cancers Symposium
- Vir Biotechnology and GSK announce NHS-supported AGILE study to evaluate VIR-7832 in the early treatment of COVID-19
Tweets from GSK US
-
GSKUS @GSKUS
Our recent #COPD survey revealed the invaluable role that #caregivers play in their loved one’s disease management. Learn more about how bringing a caregiver to an in-person or #telehealth doctor appointment can help change the conversation and improve COPD care.
about 3 hours ago -
GSKUS @GSKUS
#Cancer doesn’t stop because of a pandemic. Our own Michael Petroutsas RPh, SVP, US Oncology, discussed 4 ways the #COVID19 pandemic has changed #oncology for good, & how our teams quickly adapted to continue putting patients first. gsk.to/3o3pzix
about 6 days ago
-
GSKUS @GSKUS
#HCPs: Do your 50+ patients know that they are at risk of developing #shingles, even if they are healthy and active? Find resources to share with your patients on our #ShinglesDoesntPlayFavorites page: 👉gsk.to/3qt44tpd
about 6 days ago
Jj
